Removing Financial Toxicity From Oncology Clinical Trials Through Patient Reimbursement Programs

Did you know that less than five percent of eligible patients participate in cancer clinical trials? Out-of-pocket costs and travel burdens can present significant recruitment challenges for some of the most desperately sought after research treatments.

In honor of World Cancer Day, Greenphire hosted a one-hour panel discussion about overcoming the financial and logistical hurdles that limit patient participation in oncology research. 

View now for an eye-opening look at the barriers affecting the most at-risk patients, and the solutions that can maximize diverse clinical trial enrollment.

Learn what sites, CROs, and patient advocacy groups are doing to make clinical trials accessible to more patients:

• How their organizations have shifted to remove the burdens from oncology patients
• Specific initiatives for diversifying cancer research
• What can technology do to support decentralized trials?